Literature DB >> 11493225

Cardiovascular effects of domperidone in patients with Parkinson's disease treated with apomorphine.

G R Sigurdardóttir1, C Nilsson, P Odin, M Grabowski.   

Abstract

OBJECTIVES: The cardiovascular effects of the peripheral dopamine D2-receptor antagonist domperidone were studied in patients with idiopathic Parkinson's disease treated with continuous subcutaneous infusion of apomorphine.
MATERIAL AND METHODS: Blood pressure and heart rate of 10 patients were monitored for 24 h before and after treatment with domperidone using an automatic device for blood pressure recording.
RESULTS: Blood pressure and heart rate increased significantly during 24 h of domperidone treatment. When day and night values were analysed separately, a significant difference of blood pressure between the groups was found only during the day whereas heart rate was significantly increased during both day and night. Domperidone shifted blood pressure and heart rate upwards without affecting the drop of blood pressure in the erect position.
CONCLUSION: Domperidone increases blood pressure and heart rate without inducing nocturnal hypertension in apomorphine treated patients with idiopathic Parkinson's disease. Increased heart rate by domperidone is a new finding but the clinical significance is unclear and requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11493225     DOI: 10.1034/j.1600-0404.2001.104002092.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  6 in total

Review 1.  Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Mov Disord       Date:  2018-03       Impact factor: 10.338

2.  Increased risk of all-cause mortality associated with domperidone use in Parkinson's patients: a population-based cohort study in the UK.

Authors:  Marina Simeonova; Frank de Vries; Sander Pouwels; Johanna H M Driessen; Hubert G M Leufkens; Suzanne M Cadarette; Andrea M Burden
Journal:  Br J Clin Pharmacol       Date:  2018-08-09       Impact factor: 4.335

3.  Orthostatic hypotensive effect of antipsychotic drugs in Wistar rats by in vivo and in vitro studies of alpha1-adrenoceptor function.

Authors:  Z Nourian; T Mow; D Muftic; S Burek; M L Pedersen; J Matz; M J Mulvany
Journal:  Psychopharmacology (Berl)       Date:  2008-06-10       Impact factor: 4.530

Review 4.  Arterial hypertension, a tricky side of Parkinson's disease: physiopathology and therapeutic features.

Authors:  Alberto Mazza; Roberta Ravenni; Angelo Antonini; Edoardo Casiglia; Domenico Rubello; Paolo Pauletto
Journal:  Neurol Sci       Date:  2012-11-30       Impact factor: 3.307

5.  Domperidone, Parkinson disease and sudden cardiac death: Mice and men show the way.

Authors:  Fulvio A Scorza; Carla A Scorza; Henrique B Ferraz
Journal:  Clinics (Sao Paulo)       Date:  2016-02       Impact factor: 2.365

Review 6.  Side effects of a dopamine agonist therapy for Parkinson's disease: a mini-review of clinical pharmacology.

Authors:  Josip Anđelo Borovac
Journal:  Yale J Biol Med       Date:  2016-03-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.